Fig. 5

The antiobesity effect of combined α-tocopherol and CLA in free or nanoparticulate form by intraperitoneal administration on the HFD-fed obese rats: (A) the body weight change as compared to normal diet group during the HFD-fed period; (B) total cholesterol in plasma after HFD consumption for 8 weeks; (C) AST and ALT concentration in plasma after HFD consumption for 8 weeks; (D) BUN and CRE concentration in plasma after HFD consumption for 8 weeks; (E) TG in organs/tissues after HFD consumption for 8 weeks; (F) TNF-α in organs/tissues after HFD consumption for 8 weeks; (G) IL-1β in organs/tissues after HFD consumption for 8 weeks; and (H) IL-6 in organs/tissues after HFD consumption for 8 weeks. All data are presented as the mean of six experiments ± S.E.M. *** p < 0.001; ** p < 0.01; * p < 0.05 as compared to the HFD intervention alone